MedPath

To compare the success rate of old technique trabeculectomy versus new technique implantation of drainage device in the anterior chamber of the eye in glaucoma patients.

Phase 2
Conditions
Health Condition 1: H408- Other glaucoma
Registration Number
CTRI/2023/08/056128
Lead Sponsor
Jawaharlal nehru medical college SAWANGI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with uncontrolled primary glaucoma.

2)Patients who will be diagnosed with secondary glaucoma.

3)Patients who will be diagnosed with refractory glaucoma.

4)Patients are consenting to study/ giving valid consent.

Exclusion Criteria

1)Patients with any ocular infection.

2)Patients having corneal decompensation.

3)Patients with neovascular glaucoma.

4)Patients who did not successfully complete a minimum 1-year follow-up period were not included in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Visual acuity testing by Snellen’s chart- <br/ ><br>It is used to assess distant visual acuity. The patient is seated 6m away from Snellens chart & is instructed to read the chart with both eyes, one after the other. When the patient can read up to a 6 m line, his visual acuity is reported as 6/6, & depending on the smallest line that the patient can read from a 6 m distance, his vision is recorded as 6/9, 6/12, 6/18, 6/24, 6/36, & 6/60. <br/ ><br>2)Intra Ocular Pressure measurement by applanation tonometry- <br/ ><br>The Goldmann Applanation Tonometer is commonly recognised as the gold standard in intraocular pressure (IOP) measurement. A topical anaesthetic is instilled into the conjunctival sac, followed by a fluorescein stain. The cobalt blue filter reveals a pattern of two green semicircular mires, with the inner borders of semicircles aligned. The IOP is calculated by multiplying the dial value by ten in mmhg. <br/ ><br>Timepoint: 2 YEARS
Secondary Outcome Measures
NameTimeMethod
1)Moorfields bleb grading- <br/ ><br>The bleb is assessed & characterized with respect to- <br/ ><br>•Diffusion area <br/ ><br>•Height <br/ ><br>•Vascularity in central, peripheral bleb area and non- bleb area. <br/ ><br>2)Need of anti-glaucoma medication-If the post-operative IOP measurement indicates greater values, we will administer anti-glaucoma drugs later. <br/ ><br>3)OCT-RNFL and Humphrey visual field analysis <br/ ><br>Timepoint: 2 YEARS
© Copyright 2025. All Rights Reserved by MedPath